Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 213-067-8 | CAS number: 921-53-9
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Exposure related observations in humans: other data
Administrative data
- Endpoint:
- exposure-related observations in humans: other data
- Type of information:
- experimental study
- Adequacy of study:
- weight of evidence
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: The study has been assessed for the use in a category approach. According to the methodology and to the extent of available details, the study has been judged as reliable with restrictions.
Data source
Reference
- Reference Type:
- publication
- Title:
- The effect of tartrates on the human kidney
- Author:
- Post
- Year:
- 1 914
- Bibliographic source:
- Journal of the American Medical Association. 1914; 62,(8): 592-593
Materials and methods
- Type of study / information:
- Observations were accordingly made on several patients in the service of Dr. Frank Billings and occupying the Sprague Institute beds in the Presbyterian Hospital. Potassium and sodium tartrate was given by mouth to ordinarily well-fed adults. The dose was from 1 to 6 drams, the average dose authorized by the U. S. Pharmacopeia being 2 drams. Each voiding of urine was put into separate clean sterile bottles and placed at once in an ice-box. The test for albumin was by the use of acetic acid and potassium ferrocyanid. The hydrogen ion concentration was determined, in some of the cases, by means of indicators. The observation regards the effects of tartrate on the kidney.
- Endpoint addressed:
- repeated dose toxicity: oral
Test guideline
- Qualifier:
- no guideline followed
- Principles of method if other than guideline:
- no data
- GLP compliance:
- not specified
Test material
- Reference substance name:
- Rochelle salt
- IUPAC Name:
- Rochelle salt
- Test material form:
- not specified
- Details on test material:
- No details on test material identity are available.
Constituent 1
Method
- Ethical approval:
- not applicable
- Details on study design:
- no data
- Exposure assessment:
- not specified
- Details on exposure:
- Potassium and sodium tartrate was given by mouth to ordinarily well-fed adults. The dose was from 1 to 6 drams.
Results and discussion
- Results:
- Overall, after urine examination are detected:
- no albumin;
- faint trace nucleo-albumin;
- occasional hyaline and hyalogranular cast;
- occasional leukocyte;
- sediment same plus numerous spermatozoa ;
- reaction same faint trace nucleoalbumin;
- sediment;
- urate occasional cylindroid.
Any other information on results incl. tables
Endpoint | Effect level | Based on | Sex | Observation | |
urine examination | 2-6 drams | test mat. | man | CASE 1 Moderately advanced arteriosclerosis. Urine examinations in different time: - no albumin - faint trace nucleo-albumin; occasional hyaline and hyalogranular cast, occasional leukocyte. Reaction neutral to paranitrophenol - faint trace serumalbumin; sediment same. Reaction neutral to methyl red - no albumin. Few casts. Reaction neutral to rosolie acid - no albumin. Sediment same. Neutral to rosolie acid - faint trace nucleoalbumin. Sediment same plus numerous spermatozoa ;reaction same - distinct trace serum albumin; occasional hyaline cast; neutral to rosolie acid - seven specimens ; two showed faint trace nucleo-albumin, others no albumin. All neutral to rosolie acid; sediments same as above - no albumin; sediment same; neutral to methyl red | |
urine examination |
2 drams | test mat. | man | CASE 2 Acute bronchitis - faint trace nucleoalbumin. Sediment; urate occasional cylindroid. - faint trace nucleoalbumin; numerous cylindroids - No albumin. Sediment, numerous cylindroids. | |
urine examination | 2 drams | test mat. | Woman | CASE 3 Hysteric hemiplegia, right-sided pyelitis (interval). - faint trace nucleoalbumin sediment; moderate number of leukocytes; bacilli, neutral to rosolie acid - faint trace nucleoalbumin; sediment same; neutral to paranitrophenol - faint trace nucleo-albumin; sediment same; neutral to rosolie acid | |
urine examination | 2 -3 drams | test mat. | man | CASE 4 Acute bronchitis. - no albumin; few mucus threads; occasional leukocyte - no albumin; sediment same as above - faint trace albumin; numerous cylindroids; no casts - no albumin; sediment same as above | |
urine examination | 3 drams | test mat. | male | CASE 5 Lumbago; tonsillectomy. - acid to litmus; distinct trace albumin; few hyalogranular casts - neutral to rosolie acid; distinct trace albumin; ruther numerous leukocytes; occasional cast - neutral to rosolie acid; no albumin; sediment same - neutral to methyl red; faint trace nucleo-albumin | |
urine examination | 3 drams | test mat. | male | CASE 6 Acute tonsillitis. - neutral to paranitro phenol; faint trace albumin; mates and calcium oxalate crystals - practically same findings except no crystals - faint trace albumin; urates - neutral to paranitrophenol; faint trace albumin; urates - neutral to rosolie acid; no albumin; occasional cylindroid and hyalogranular cast - neutral to methyl red; faint trace nucleo-albumin and serum albumin - neutral to paranitrophenol; no albumin | |
urine examination | 2 drams | test mat | male | CASE 7 Osteo-arthritis - urinalysis showed no albumin or casts - prolonged attack of diarrhea with severe abdominal cramps - the legs and scrotum were markedly edematous and there was free fluid in the abdomen and fluid in the right chest - urinalysis showed a large amount of albumin and many hyaline and granular and epithelial casts |
Applicant's summary and conclusion
- Conclusions:
- These cases study give no evidence indicating that potassium sodium tartrate in ordinary doses given by mouth in the human subject will cause albuminuria or cylindruria. There is no evidence to show that tartrates aggravate an existing nephritis. The acidity of the urine, indicated by the hydrogen ion concentration, was as a rule less after the administration of tartrates.
- Executive summary:
These cases study give no evidence indicating that potassium sodium tartrate in ordinary doses given by mouth in the human subject will cause albuminuria or cylindruria. There is no evidence to show that tartrates aggravate an existing nephritis. The acidity of the urine, indicated by the hydrogen ion concentration, was as a rule less after the administration of tartrates.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.

EU Privacy Disclaimer
This website uses cookies to ensure you get the best experience on our websites.